Creso Pharma Ltd
ASX:CPH
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| AU |
|
Creso Pharma Ltd
ASX:CPH
|
17.7m AUD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
978.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
571.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.8B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.9B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.8B USD |
Loading...
|
Market Distribution
| Min | -6 907 100% |
| 30th Percentile | 21.6% |
| Median | 38.3% |
| 70th Percentile | 58.2% |
| Max | 2 095.9% |
Other Profitability Ratios
Creso Pharma Ltd
Glance View
Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 2 years, Creso Pharma Ltd’s Gross Margin has decreased from 5.9% to 4.2%. During this period, it reached a low of 4.2% on Jan 31, 2023 and a high of 5.9% on Dec 1, 2020.
